BCR and COVID-19: In this study, paired PBMC-derived BCR repertoires of five convalescent COVID-19 HDs showed that the expression of IGHV1-69/IGKV2-28 and IGHV1-69/IGKV3-20 was weak in both patients with COVID-19 and HDs.